BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32502498)

  • 1. The two faces of giant cell tumor of bone.
    Scotto di Carlo F; Whyte MP; Gianfrancesco F
    Cancer Lett; 2020 Oct; 489():1-8. PubMed ID: 32502498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF687 Mutations in an Extended Cohort of Neoplastic Transformations in Paget's Disease of Bone: Implications for Clinical Pathology.
    Scotto di Carlo F; Pazzaglia L; Mumm S; Benassi MS; De Chiara A; Franchi A; Parafioriti A; Righi A; Esposito T; Whyte MP; Gianfrancesco F
    J Bone Miner Res; 2020 Oct; 35(10):1974-1980. PubMed ID: 32106343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location.
    Scotto di Carlo F; Divisato G; Iacoangeli M; Esposito T; Gianfrancesco F
    BMC Cancer; 2018 Apr; 18(1):358. PubMed ID: 29609578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histogenesis of giant cell tumors].
    Wuelling M; Engels C; Jesse N; Werner M; Kaiser E; Delling G
    Pathologe; 2002 Sep; 23(5):332-9. PubMed ID: 12376858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular differences between giant-cell tumour of soft tissue and its bone counterpart.
    Mancini I; Righi A; Gambarotti M; Picci P; Dei Tos AP; Billings SD; Simi L; Franchi A
    Histopathology; 2017 Sep; 71(3):453-460. PubMed ID: 28477388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells.
    Mak IW; Turcotte RE; Ghert M
    Bone; 2013 Jul; 55(1):198-207. PubMed ID: 23466453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences.
    Divisato G; Scotto di Carlo F; Pazzaglia L; Rizzo R; Coviello DA; Benassi MS; Picci P; Esposito T; Gianfrancesco F
    Oncotarget; 2017 Sep; 8(38):63121-63131. PubMed ID: 28968976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts.
    Zheng MH; Robbins P; Xu J; Huang L; Wood DJ; Papadimitriou JM
    Histol Histopathol; 2001 Jan; 16(1):297-307. PubMed ID: 11193206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant Cell Tumor of Bone With Cartilage Matrix: A Clinicopathologic Study of 17 Cases.
    Brčić I; Yamani F; Inwards CY; Sumathi V; Dodd L; Kreiger PA; Sittampalam K; Allred TR; Kashofer K; Liegl-Atzwanger B; Kerr DA; Nielsen GP; Rosenberg AE
    Am J Surg Pathol; 2020 Jun; 44(6):748-756. PubMed ID: 32412716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone H3.3 mutation in giant cell tumor of bone: an update in pathology.
    Yamamoto H; Ishihara S; Toda Y; Oda Y
    Med Mol Morphol; 2020 Mar; 53(1):1-6. PubMed ID: 31748824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha.
    Rao VH; Singh RK; Delimont DC; Finnell RH; Bridge JA; Neff JR; Garvin BP; Pickering DL; Sanger WG; Buehler BA; Schaefer GB
    Int J Oncol; 1999 Feb; 14(2):291-300. PubMed ID: 9917505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and localization of extracellular matrix metalloproteinase inducer in giant cell tumor of bone.
    Si AI; Huang L; Xu J; Kumta SM; Wood D; Zheng MH
    J Cell Biochem; 2003 Aug; 89(6):1154-63. PubMed ID: 12898514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bone morphogenetic proteins in giant cell tumor of bone.
    Kudo N; Ogose A; Ariizumi T; Kawashima H; Hotta T; Hatano H; Morita T; Nagata M; Siki Y; Kawai A; Hotta Y; Hoshino M; Endo N
    Anticancer Res; 2009 Jun; 29(6):2219-25. PubMed ID: 19528484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drivers underpinning the malignant transformation of giant cell tumour of bone.
    Fittall MW; Lyskjaer I; Ellery P; Lombard P; Ijaz J; Strobl AC; Oukrif D; Tarabichi M; Sill M; Koelsche C; Mechtersheimer G; Demeulemeester J; Tirabosco R; Amary F; Campbell PJ; Pfister SM; Jones DT; Pillay N; Van Loo P; Behjati S; Flanagan AM
    J Pathol; 2020 Dec; 252(4):433-440. PubMed ID: 32866294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells.
    Fellenberg J; Sähr H; Mancarella D; Plass C; Lindroth AM; Westhauser F; Lehner B; Ewerbeck V
    Cancer Lett; 2019 Apr; 448():61-69. PubMed ID: 30742944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.
    Huang L; Xu J; Wood DJ; Zheng MH
    Am J Pathol; 2000 Mar; 156(3):761-7. PubMed ID: 10702390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZNF687 Mutations in Severe Paget Disease of Bone Associated with Giant Cell Tumor.
    Divisato G; Formicola D; Esposito T; Merlotti D; Pazzaglia L; Del Fattore A; Siris E; Orcel P; Brown JP; Nuti R; Strazzullo P; Benassi MS; Cancela ML; Michou L; Rendina D; Gennari L; Gianfrancesco F
    Am J Hum Genet; 2016 Feb; 98(2):275-86. PubMed ID: 26849110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of H3F3A p.G35W and p.G35R in giant cell tumor of bone by Allele Specific Locked Nucleic Acid quantitative PCR (ASLNAqPCR).
    Gamberi G; Morandi L; Benini S; Resca A; Cocchi S; Magagnoli G; Donati DM; Righi A; Gambarotti M
    Pathol Res Pract; 2018 Jan; 214(1):89-94. PubMed ID: 29254795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
    Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
    J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3F3A (Histone 3.3) G34W Immunohistochemistry: A Reliable Marker Defining Benign and Malignant Giant Cell Tumor of Bone.
    Amary F; Berisha F; Ye H; Gupta M; Gutteridge A; Baumhoer D; Gibbons R; Tirabosco R; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2017 Aug; 41(8):1059-1068. PubMed ID: 28505000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.